David Pinsky - Ann Harbor MI, US Tucker Collins - Cohasset MA, US
International Classification:
C12Q001/68 C12Q001/02
US Classification:
435 6, 435 29
Abstract:
This invention provides methods for determining whether an agent increases PPAR-γ-mediated inhibition of Egr-1 expression. This invention also provides methods for inhibiting the onset of atherosclerosis in a transplanted organ. This invention further provides numerous methods for treating disorders, and/or inhibiting the onset of disorders or disorder-related complications by using PPAR-γ agonists. This invention still further provides related methods for inhibiting cancer metastasis, treating and inhibiting the onset of a heart attack, and treating burn and crush injuries. Finally, this invention provides related articles of manufacture.
Mononuclear Leukocyte Directed Endothelial Adhesion Molecule Associated With Atherosclerosis
Michael A. Gimbrone - Boston MA Myron I. Cybulsky - Allston MA Tucker Collins - Cohasset MA
Assignee:
Brigham & Women's Hospital - Boston MA
International Classification:
C07K 1400
US Classification:
5303887
Abstract:
The invention relates to novel endothelial cell-leukocyte adhesion molecules designated ATHERO-ELAM. ATHERO-ELAM molecules are expressed on cultured endothelial cells stimulated with bacterial LPS and selectively mediate the binding of monocytes to the endothelial cells. Monoclonal antibodies specific for ATHERO-ELAM bind to vascular endothelial cells involved in early atherosclerotic lesions, but not to vascular endothelial cells from uninvolved arterial tissue. ATHERO-ELAM and antibodies directed to ATHERO-ELAM may be used in identifying early atherosclerotic lesions and in treating and preventing atherosclerosis.
Isbn (Books And Publications)
Pocket Companion to Robbins Pathologic Basis of Disease